BioCentury
ARTICLE | Company News

Gencia, Myelin Repair Foundation deal

August 19, 2013 7:00 AM UTC

Gencia and the foundation partnered to evaluate the myelin regenerating capabilities of Gencia's preclinical compounds for multiple sclerosis (MS) using the research tools and assays at the foundation...